Europa
Exciva’s Alzheimer’s treatments raise €51 million
The German start-up receives capital in a Series B round led by Gimv and EQT Life Sciences and prepares for the second phase of clinical trials
The German start-up receives capital in a Series B round led by Gimv and EQT Life Sciences and prepares for the second phase of clinical trials